Role of heteromeric gap junctions in the cytotoxicity of cisplatin

Toxicology

Volumn 310, Issue , 2013, Pages 53-60

  Tong, Xuhui ^a,b   Dong, Shuying ^a   Yu, Meiling ^a   Wang, Qin ^b   Tao, Liang ^b  

^a BENGBU MEDICAL COLLEGE   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Apoptosis; Bystander effect; Caspase; Cisplatin; Gap junction

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CISPLATIN; OLEAMIDE; RETINOIC ACID;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; GAP JUNCTION; HELA CELL; HETEROMERIC GAP JUNCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

APOPTOSIS; BYSTANDER EFFECT; CASPASE; CISPLATIN; GAP JUNCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; CELL COMMUNICATION; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL SURVIVAL; CISPLATIN; CONNEXINS; FLOW CYTOMETRY; GAP JUNCTIONS; HELA CELLS; HUMANS; TRANSFECTION;

EID: 84879833898     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2013.05.010     Document Type: Article

References (38)

1. Arany I., Megyesi J.K., Kaneto H., Price P.M., Safirstein R.L. Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells. Am. J. Physiol. Renal Physiol. 2004, 287:F543-F549.
2. Autsavapromporn N., De Toledo S.M., Jay-Gerin J.P., Harris A.L., Azzam E.I. Human cell responses to ionizing radiation are differentially affected by the expressed connexins. J. Radiat. Res. 2013, 54:251-259.
3. Ayad W.A., Locke D., Koreen I.V., Harris A.L. Heteromeric, but not homomeric, connexin channels are selectively permeable to inositol phosphates. J. Biol. Chem. 2006, 281:16727-16739.
4. Bevans C.G., Kordel M., Rhee S.K., Harris A.L. Isoform composition of connexin channels determines selectivity among second messengers and uncharged molecules. J. Biol. Chem. 1998, 273:2808-2816.
5. Colombo B.M., Benedetti S., Ottolenghi S., Mora M., Pollo B., Poli G., Finocchiaro G. The bystander effect: association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Hum. Gene Ther. 1995, 6:763-772.
6. Czyz J., Szpak K., Madeja Z. The role of connexins in prostate cancer promotion and progression. Nat. Rev. Urol. 2012, 9:274-282.
7. Decrock E., Krysko D.V., Vinken M., Kaczmarek A., Crispino G., Bol M., Wang N., De Bock M., De Vuyst E., Naus C.C., Rogiers V., Vandenabeele P., Erneux C., Mammano F., Bultynck G., Leybaert L. Transfer of IP(3) through gap junctions is critical, but not sufficient, for the spread of apoptosis. Cell Death Differ. 2012, 19:947-957.
8. 2+ entry through plasma membrane IP3 receptors. Science 2006, 313:229-233.
9. Fick J., Barker F.G., Dazin P., Westphale E.M., Beyer E.C., Israel M.A. The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:11071-11075.
10. Hanigan M.H., Devarajan P. Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther. 2003, 1:47-61.
11. Harris A.L. Connexin channel permeability to cytoplasmic molecules. Prog. Biophys. Mol. Biol. 2007, 94:120-143.
12. He B., Tong X., Wang L., Wang Q., Ye H., Liu B., Hong X., Tao L., Harris A.L. Tramadol and flurbiprofen depress the cytotoxicity of cisplatin via their effects on gap junctions. Clin. Cancer Res. 2009, 15:5803-5810.
13. Hong X., Wang Q., Yang Y., Zheng S., Tong X., Zhang S., Tao L., Harris A.L. Gap junctions propagate opposite effects in normal and tumor testicular cells in response to cisplatin. Cancer Lett. 2012, 317:165-171.
14. Huang T., Zhu Y., Fang X., Chi Y., Kitamura M., Yao J. Gap junctions sensitize cancer cells to proteasome inhibitor MG132-induced apoptosis. Cancer Sci. 2010, 101:713-721.
15. Ionta M., Rosa M.C., Almeida R.B., Freitas V.M., Rezende-Teixeira P., Machado-Santelli G.M. Retinoic acid and cAMP inhibit rat hepatocellular carcinoma cell proliferation and enhance cell differentiation. Braz. J. Med. Biol. Res. 2012, 45:721-729.
16. Jaffe L.F. A calcium-based theory of carcinogenesis. Adv. Cancer Res. 2005, 94:231-263.
17. Jensen R., Glazer P.M. Cell-interdependent cisplatin killing by Ku/DNA-dependent protein kinase signaling transduced through gap junctions. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:6134-6139.
18. Kalvelyte A., Imbrasaite A., Bukauskiene A., Verselis V.K., Bukauskas F.F. Connexins and apoptotic transformation. Biochem. Pharmacol. 2003, 66:1661-1672.
19. Kelsey L., Katoch P., Johnson K.E., Batra S.K., Mehta P.P. Retinoids regulate the formation and degradation of gap junctions in androgen-responsive human prostate cancer cells. PLoS ONE 2012, 7:e32846.
20. Koreen I.V., Elsayed W.A., Liu Y.J., Harris A.L. Tetracycline-regulated expression enables purification and functional analysis of recombinant connexin channels from mammalian cells. Biochem. J. 2004, 383:111-119.
21. Krutovskikh V.A., Piccoli C., Yamasaki H. Gap junction intercellular communication propagates cell death in cancerous cells. Oncogene 2002, 21:1989-1999.
22. Krysko D.V., Leybaert L., Vandenabeele P., D'Herde K. Gap junctions and the propagation of cell survival and cell death signals. Apoptosis 2005, 10:459-469.
23. Locke D., Koreen I.V., Harris A.L. Isoelectric points and post-translational modifications of connexin26 and connexin32. FASEB J. 2006, 20:1221-1223.
24. Locke D., Stein T., Davies C., Morris J., Harris A.L., Evans W.H., Monaghan P., Gusterson B. Altered permeability and modulatory character of connexin channels during mammary gland development. Exp. Cell Res. 2004, 298:643-660.
25. Mandic A., Viktorsson K., Strandberg L., Heiden T., Hansson J., Linder S., Shoshan M.C. Calpain-mediated Bid cleavage and calpain-independent Bak modulation: two separate pathways in cisplatin-induced apoptosis. Mol. Cell Biol. 2002, 22:3003-3013.
26. Marzano C., Bettio F., Baccichetti F., Trevisan A., Giovagnini L., Fregona D. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity. Chem. Biol. Interact. 2004, 148:37-48.
27. Mesnil M., Piccoli C., Tiraby G., Willecke K., Yamasaki H. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:1831-1835.
28. Park H.H. Structural features of caspase-activating complexes. Int. J. Mol. Sci. 2012, 13:4807-4818.
29. Ryu C.H., Park K.Y., Kim S.M., Jeong C.H., Woo J.S., Hou Y., Jeun S.S. Valproic acid enhances anti-tumor effect of mesenchymal stem cell mediated HSV-TK gene therapy in intracranial glioma. Biochem. Biophys. Res. Commun. 2012, 421:585-590.
30. Schloffer D., Horky M., Kotala V., Wesierska-Gadek J. Induction of cell cycle arrest and apoptosis in human cervix carcinoma cells during therapy by cisplatin. Cancer Detect. Prev. 2003, 27:481-493.
31. Tanaka M., Fraizer G.C., De La Cerda J., Cristiano R.J., Liebert M., Grossman H.B. Connexin 26 enhances the bystander effect in HSVtk/GCV gene therapy for human bladder cancer by adenovirus/PLL/DNA gene delivery. Gene Ther. 2001, 8:139-148.
32. Tao L., Harris A.L. 2-Aminoethoxydiphenyl borate directly inhibits channels composed of connexin26 and/or connexin32. Mol. Pharmacol. 2007, 71:570-579.
33. Udawatte C., Ripps H. The spread of apoptosis through gap-junctional channels in BHK cells transfected with Cx32. Apoptosis 2005, 10:1019-1029.
34. Vichai V., Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat. Protoc. 2006, 1:1112-1116.
35. Wang M., Berthoud V.M., Beyer E.C. Connexin43 increases the sensitivity of prostate cancer cells to TNFalpha-induced apoptosis. J. Cell Sci. 2007, 120:320-329.
36. Wang Q., Zheng X.L., Yang L., Shi F., Gao L.B., Zhong Y.J., Sun H., He F., Lin Y., Wang X. Reactive oxygen species-mediated apoptosis contributes to chemosensitization effect of saikosaponins on cisplatin-induced cytotoxicity in cancer cells. J. Exp. Clin. Cancer Res. 2010, 29:159.
37. Weber P.A., Chang H.C., Spaeth K.E., Nitsche J.M., Nicholson B.J. The permeability of gap junction channels to probes of different size is dependent on connexin composition and permeant-pore affinities. Biophys. J. 2004, 87:958-973.
38. Zimmermann K.C., Bonzon C., Green D.R. The machinery of programmed cell death. Pharmacol. Ther. 2001, 92:57-70.